B0RUA4 Glutamyl-tRNA reductase MolNFT, Molecular NFT on GenesisL1

Glutamyl-tRNA reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD

IPFS of NFT metadata:

bafybeiacxas7rw354jar5q4776vr2elzgqu7swyzfit2fkhxqpzeuublte/metadata.json

IPFS of structure file:

bafybeiftz52q5ffwa5zutkyklopbgpnjppnbq7gfwfrydluz5tkhxqkljy/AF-B0RUA4-F1-model_v2.pdb

First NFT owner address (eip-55):

0x98c95d7EC463682453dDA6620Db0cecEae0560fA

First NFT owner address (bech32):

genesis1nry46lkyvd5zg57a5e3qmvxwe6hq2c86g87wll

Current NFT ID #166987 owner (web3):

0x32487a5305f4984ca258817a77b56Dc58ab8670B

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
166987
Accession (UniProt):
B0RUA4
Name::
Glutamyl-tRNA reductase
Experimental Method:
Predicted structure
Sequence source:
XANTHOMONAS CAMPESTRIS PV. CAMPESTRIS (STRAIN B100)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B0RUA4 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B0RUA4|HEM1_XANCB Glutamyl-tRNA reductase OS=Xanthomonas campestris pv. campestris (strain B100) OX=509169 GN=hemA PE=3 SV=1 MTLWVLGLNHQTAPVDLRERAAFAGDALPRALDSLRTLPQVREAALLSTCNRTELYAMADDPQTLVAWLDMHAPGLSGYLYQHRDAEAVRHLFRVATGLDSMVLGEPQILGQVKDAWAVARAHGALGSGLDRLFQQTFSVAKRARTDTRVGANPVSVASTAVRLAQESFARLNESTVLLVGAGETIELAAKHLSEGRVRRLLIANRTLAHAQTLATQHGGVALPLTELDRHLAEADVVFSATAAREPVVTRVQVEQALRTRKRKPMLLFDLAVPRDIEASVAELSDAYLYTVDDLERAVEDNRRSRREAADQAEAIIDLQVARYVETLQANERQAPLKRLRAFGDSTRDELLAKARQQLSNGKPADEVLEQLAHALTNRLLHPPTAALRDAALNNDLDLTSAADRLFPEKPGYRHPPVATPIVRTDDANPAP

B0RUA4 AF NFT

MOLNFT AF v1

NFT data

MOLNFT B0RUA4 research and analysis (ICN3D with VR)

FASTA sequences

We use cookies on this site to enhance your user experience